Point72 Hong Kong LTD Y M Abs Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$15.51 - $29.31 $15,432 - $29,163	-995 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $27,332 - $37,123	995 New	995 $28,000
Q1 2021 May 17, 2021	SELL	$29.16 - $51.96 $16,912 - $30,136	-580 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $21,958 - $31,470	580 New	580 $29,000
Q4 2018 Feb 14, 2019	SELL	$15.41 - $28.92 $50,113 - $94,047	-3,252 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$24.0 - $26.97 $78,048 - $87,706	3,252 New	3,252 $86,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.